Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.
Vaccine policy, Medicare drug negotiations, and a potential DTC advertising ban will all fall under Kennedy’s purview as HHS ...
Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...
Dr Aseem Malhotra, a doctor tapped for a job in the Department of Health and Human Services, now headed by Robert F Kennedy ...
HHS Secretary Robert F. Kennedy Jr. said any staffers in the department who are "working for the pharmaceutical industry" ...
U.K.-based ad agency DAIVID said Pfizer had a strong, positive message with its ad and scored high with intense positive emotions. The commercial was also a top performer with spikes in positive ...
Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...
Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
Novartis NVS and AbbVie ABBV announced small M&A deals. The FDA approved the expanded use of Pfizer’s PFE cancer drug ...
Many investors seemed to view Nvidia's decision to maintain its stake in Recursion as a vote of confidence in the company.
Two biotechs say they’re using AI to conjure drugs from scratch. Their documents suggest otherwise
A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI ...
Flexible automation will play a growing role of in warehouse operations. As the industry shifts towards more adaptable, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback